Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Amyotrophic lateral sclerosis

Recruiting

Registered drug

Study on the Effects of EH-301, N-Acetylcysteine, and Riluzole in Patients with Amyotrophic Lateral Sclerosis (ALS)

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Acetylcysteine

Contact Research Centre

Malignant melanoma

Recruiting

Registered drugNo placebo

Study on Encorafenib, Binimetinib, Cemiplimab, and Fianlimab for Patients with BRAF-Mutated Melanoma and Brain Metastases

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Small cell lung cancer limited stage

Recruiting

Investigational

Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:TIFCEMALIMAB

Contact Research Centre

Chronic graft versus host disease

Recruiting

Registered drug

Study on Axatilimab and Corticosteroids for Initial Treatment of Chronic Graft-Versus-Host Disease in Patients

Registered drug

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Axatilimab

Contact Research Centre

Bladder transitional cell carcinoma

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Mitomycin C with Electric Current for Treating Non-Muscle Invasive Bladder Cancer in Patients, Compared to Standard Immunotherapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Mitomycin

Contact Research Centre

Glaucoma+1

Recruiting

Registered drugNo placebo

Study on the Effectiveness of PRGF Eye Drops for Treating Dry Eye in Glaucoma Patients

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Platelet Concentrate

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Art6043

Contact Research Centre

Endocarditis enterococcal

Recruiting

Registered drugNo placebo

Study on Continuous vs. Intermittent Infusion of Ampicillin and Ceftriaxone for Patients with Enterococcus faecalis Infective Endocarditis

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Amoxicillin

Contact Research Centre

Endometrial cancer+5

Recruiting

Registered drugNo placebo

Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

B-cell lymphoma recurrent

Recruiting

Registered drugNo placebo

Study on Axicabtagene Ciloleucel for Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Clostridium difficile infection

Recruiting

Investigational

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live

Contact Research Centre

Find therapies in clinical trials near you – page 4

206 trials match your criteria

Amyotrophic lateral sclerosis

Study on the Effects of EH-301, N-Acetylcysteine, and Riluzole in Patients with Amyotrophic Lateral Sclerosis (ALS)

Malignant melanoma

Study on Encorafenib, Binimetinib, Cemiplimab, and Fianlimab for Patients with BRAF-Mutated Melanoma and Brain Metastases

Chronic lymphocytic leukaemia+1

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Small cell lung cancer limited stage

Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Chronic graft versus host disease

Study on Axatilimab and Corticosteroids for Initial Treatment of Chronic Graft-Versus-Host Disease in Patients

Bladder transitional cell carcinoma

Study on the Effectiveness and Safety of Mitomycin C with Electric Current for Treating Non-Muscle Invasive Bladder Cancer in Patients, Compared to Standard Immunotherapy

Glaucoma+1

Study on the Effectiveness of PRGF Eye Drops for Treating Dry Eye in Glaucoma Patients

Neoplasm malignant

Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

Endocarditis enterococcal

Study on Continuous vs. Intermittent Infusion of Ampicillin and Ceftriaxone for Patients with Enterococcus faecalis Infective Endocarditis

Endometrial cancer+5

Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

B-cell lymphoma recurrent

Study on Axicabtagene Ciloleucel for Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

Clostridium difficile infection

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.